Form 8-K - Current report:
SEC Accession No. 0001683168-24-008550
Filing Date
2024-12-06
Accepted
2024-12-06 17:12:16
Documents
19
Period of Report
2024-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT stemtech_8k.htm   iXBRL 8-K 58159
2 MERGER AGREEMENT BY AND BETWEEN THE COMPANY AND SEACRET DIRECT, LLC stemtech_ex0201.htm EX-2.1 212401
3 PRESS RELEASE stemtech_ex9901.htm EX-99.1 12321
4 PRESS RELEASE stemtech_ex9902.htm EX-99.2 32129
8 GRAPHIC image_001.jpg GRAPHIC 3879
9 GRAPHIC image_002.jpg GRAPHIC 3316
10 GRAPHIC image_003.jpg GRAPHIC 2803
  Complete submission text file 0001683168-24-008550.txt   559066

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE stek-20241202.xsd EX-101.SCH 3015
6 XBRL LABEL FILE stek-20241202_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE stek-20241202_pre.xml EX-101.PRE 24165
21 EXTRACTED XBRL INSTANCE DOCUMENT stemtech_8k_htm.xml XML 3665
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (954) 715-6000
Stemtech Corp (Filer) CIK: 0001511820 (see all company filings)

EIN.: 872151440 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-172172 | Film No.: 241533173
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)